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doi:10.1016/j.ejvs.2008.01.027Abstract Objective: To evaluate healing time of ischaemic tissue lesions, limb salvage and
survival in patients suffering from critical limb ischaemia (CLI) with tissue loss.
Design: Prospective single centre cohort study.
Material and methods: Consecutive patients with CLI and tissue loss (Fontaine IV) (148 pa-
tients, 150 limbs) were followed prospectively for 1 year after infrainguinal bypass. Healing
time of tissue lesions, graft patency, limb salvage, survival rates and the overall need for
any type of surgical and endovascular procedure were analysed. Patient comorbidities were
assessed by uni- and multivariate analysis to determine risk factors for adverse outcome.
Results: Complete tissue healing, including healing of ischaemic tissue lesions and surgical
wounds, at 6 and 12 months after the infrainguinal bypass were respectively 40% and 75%.
The median time to complete tissue healing was 190 days. Diabetes was the only significant
risk factor which delayed tissue healing. Overall patency, limb salvage, survival and amputa-
tion-free survival rates were respectively at 12 months 80%, 81%, 73% and 63%. The clinically
important endpoint amputation-free survival with completely healed wounds was attained in
50% of patients at 1 year.
Conclusion: Complete healing of ischemic tissue lesions is slow even after a successful infrain-
guinal bypass.
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Generally it is assumed that in critical limb ischaemia (CLI)
the viability of the leg is threatened, unless some improve-
ment of the arterial supply is undertaken. The risk of major
amputation is greater in legs with ischaemic lesions (CLI
Fontaine IV) than in legs with rest pain only (CLI Fontaine
III).1,2 As a majority of patients with CLI have multi-segmentald by Elsevier Ltd. All rights reserved.
Table 1 Patient characteristics
Condition Proportion %
Male 86/148 58
Age >80 years 49/148 33
Hyperlipidemia 69/148 46
Hypertension 106/148 72
Coronary artery disease 100/148 68
Chronic pulmonary disease 24/148 16
Cerebrovascular disease 26/148 18
Diabetes mellitus 74/148 50
ESRDa with dialysis 11/148 7
BMIb > 25 63/142c 44c
Gangrene 69/150 46
a end stage renal disease.
b body mass index.
c the information was incomplete due to missing data.
Ulcer Healing and CLI 91arterial disease3,4 and an increasing proportion are diabetics
whose arterial disease affects the infrapopliteal arteries,5
an infrainguinal bypass operation is by far the most common
surgical operation performed to save a leg.4
The results of infrainguinal bypass surgery for critical leg
ischaemia have been assessed traditionally by graft pa-
tency, limb salvage and mortality rates. These measures
underestimate patient morbidity and fail to consider the
entire spectrum of treatments required to heal the tissue
lesions and achieve limb salvage. As most of the patients
suffering from CLI are elderly and have several comorbid-
ities,6 they often experience setbacks that can require ad-
ditional treatment.7 The aim of this study was to evaluate
in how many cases complete healing of tissue lesions is
achieved within 1 year after the infrainguinal bypass for
CLI Fontaine IV (ulcer, gangrene) and to evaluate factors af-
fecting the tissue healing, graft patency, limb salvage and
survival. In addition we wanted to quantify the overall
need for any type of surgical and endovascular procedure.Table 2 Details of the 150 infrainguinal bypasses
Artery nZ 150 %
Inflow
Common femoral artery 104 69
Deep femoral artery 5 3
Superficial femoral artery 13 9
Proximal popliteal artery 6 4
Distal popliteal artery 22 15
Outflow
Proximal popliteal artery 16 11
Distal popliteal artery 32 21
Tibioperoneal trunk 1 1
Anterior tibial artery 23 15
Posterior tibial artery 25 17
Peroneal artery 21 14
Dorsal pedal artery 30 20
Plantar artery 2 1Material and Methods
The study plan was to prospectively collect 1-year follow-
up data from 150 consecutive primary infrainguinal bypass
procedures for critically ischaemic legs with tissue loss (CLI
Fontaine IV). The bypass operations were performed
between January 2005 and July 2006 in Helsinki University
Central Hospital (HUCH). HUCH serves as the academic
vascular centre for southern Finland with a catchment area
of 1.4 million inhabitants.
An ABI 0.50 or a toe systolic pressure 30 mmHg were
assumed as diagnostic criteria for critical leg ischaemia. In
patients with large tissue defects, previous toe amputation
or with medial sclerosis, the diagnosis of CLI was made by
clinical signs, symptoms and angiographically verified arte-
rial occlusions in the leg.
The study cohort consisted of 86 men (58%) and 62
women aged 44e95 years (median 76 years). Two patients
with bilateral disease had bilateral reconstructions. The
ischaemic lesion was ulcer in 81 legs (54%) and gangrene in
69 legs. Median pre-operative ankle-brachial index (ABI)
was 0.43 (range 0e2.30). Comorbidities were common and
half the patients had diabetes (Table 1).
Patients with previous infrainguinal bypass in the ischae-
mic leg were excluded. Two patients had been treated with
a supra-inguinal reconstruction and one patient with an
infra-inguinal percutaneous angioplasty (PTA) for claudica-
tion 3 years earlier. Unsuccessful PTA and recanalisation
had been performed in 22 legs (15%) to treat CLI prior to the
infrainguinal bypass. All patients underwent pre-operative
angiography to evaluate the extent of arterial occlusions
and to select appropriate inflow and outflow vessels. 15
legs (10%) required an inflow procedure before the infrain-
guinal reconstruction (Table 4). Vein grafts were used in
139 infrainguinal reconstructions (93%), 11 had prosthetic
grafts. In situ saphenous graft vein grafts were used most
frequently. The most frequent inflow site for the proximal
anastomosis of the infrainguinal bypass was the common
femoral artery, whereas the dorsal pedal artery was
selected most commonly as the outflow artery (Table 2).
Two bypasses were sequential reconstructions. The medianimmediate postoperative ABI was 0.98 (range 0.33e3.12).
Postoperatively subcutaneous low molecular weight hepa-
rin 5000 IU twice daily was administered for 1e2 weeks
and life-long aspirin (100 mg/day) was recommended, un-
less contraindicated. The patients were enrolled in the nor-
mal graft surveillance programme at our vascular
outpatient clinic at 1 month (range 3 weeks-2 months), 6
months (range 5e7 months) and 12 months (range 11e13
months) after bypass surgery. In addition to duplex surveil-
lance of the graft the routine follow-up included clinical
assessment of the foot, ABI and toe pressure measurement.
When necessary, further interventions for failing grafts or
wounds were performed.
We defined tissue healing time as the time needed to
achieve complete epithelialization of the ischaemic lesions
and surgical wounds. Local wound care was chosen,
depending on the character of each lesion. Major amputa-
tions were regarded as non-healed tissue lesions. Patients
with non-healed tissue lesions 1 month before death were
never considered to have tissue healing. The criterion for
patency was either verification of graft flow by duplex
Figure 1 Primary and secondary patency of the infrainguinal
bypasses performed to 150 legs due to CLI Fontaine IV (Kaplan-
Meier plots).
Table 3 Uni- and multivariate analysis of factors related
to healing of tissue lesions in 150 legs treated with infrain-
guinal bypass due to CLI Fontaine IV
Factor Univariate
analysisa
p-value
Multivariate analysis
HR
(95% CI)b
p-
value
Age> 80 years 0.295 0.9 (0.6e1.7) 0.912
BMIc >25 0.470 1.0 (0.6e1.6) 0.964
Cerebrovascular disease 0.729 0.9 (0.5e1.8) 0.830
Chronic pulmonary disease 0.704 0.9 (0.5e1.7) 0.840
Coronary artery disease 0.511 1.2 (0.8e2.0) 0.397
Diabetes mellitus 0.001 0.5 (0.3e0.8) 0.006
Gangrene 0.063 1.2 (0.8e2.0) 0.383
ESRDd with dialysis 0.170 0.4 (0.1e3.1) 0.392
a Kaplan-Meier method.
b Cox regression, HRZ hazard ratio.
c body mass index.
d end stage renal disease.
92 M. So¨derstro¨m et al.ultrasound or angiography or an ABI that was increased,
unchanged or decreased <0.15 compared with the imme-
diate postoperative value. Data on preoperative character-
istics, risk factors, surgical details, post-operative
outcomes and reinterventions were prospectively added
into our local vascular registry at variable time points
within the course of each patient’s care. Information about
the wound healing process was also added to the office
chart database which covered the entire university hospital
district. For this study follow-up terminated 1 year after
the infrainguinal bypass operation or at the time of major
amputation or death. Whenever a patient did not arrive for
a scheduled visit, the patient was retrieved by nurse follow-
up. Patients were considered lost to follow-up if no
information on them was retrieved after attempt to contact
them by telephone and subsequent letter as necessary.
Survival data also were gathered from the Population
Register Centre.
Statistical analysis
Data were processed using the SPSS 13.0 statistical soft-
ware package (SPSS Inc., Chicago, III, USA). Tissue healing,
limb salvage, survival, amputation-free survival and pa-
tency rates were calculated using the Kaplan-Maier
method. The statistical significance of any difference in
Kaplan-Maier analysis were tested using the log-rank test
(univariate analysis). Multivariate Cox regression analysis
provided risk ratios of clinically relevant factors for non-
healing tissue lesions, amputation and death. Differences
between groups were considered statistically significant for
p< 0.05.
Results
Five patients (3%) were lost to follow-up before reaching
any of study endpoints or complete healing of the tissue
lesions.
Patency
The overall primary patency rate at 12 months was 72%.
The assisted primary patency rate at 12 months was
73%. The secondary patency rate at 12 months was 80%
(Fig. 1). On univariate analysis end stage renal disease
(ESRD) necessitating chronic dialysis (p< 0.001), gangrene
(p< 0.001) and coronary artery disease (pZ 0.014) were
significant risk factors for graft failure. Multivariate analy-
sis identified the same risk factors for graft failure, ESRD
(Hazard ratio HR 6.5, 95% CI 2.2e19), gangrene (HR 5.1,
95% CI 1.6e16) and coronary artery disease (HR 5.6, 95%
CI 1.6e20).
Healing of tissue lesions
Healing rate of the tissue lesions was 27% at 3 months, 40%
at 6 months and 75% at 12 months. The median time to
complete healing of tissue lesions was 190 days (range 11
days to > 365 days). Diabetes was the only risk factor which
significantly delayed tissue healing both in univariate
analysis (pZ 0.001) and multivariate analysis (HR 0.5, 95%CI 0.3e0.8) (Table 3). The tissue healing rates in patients
with and without diabetes were respectively at 6 months
26% and 53% and at 12 months 63% and 87% (Fig. 2). The
median time to tissue healing in patients with diabetes
was 213 days and 159 days for those without diabetes.
Limb salvage
The overall cumulative limb salvage rate at 12 months was
81%. On univariate analysis gangrene (p< 0.001), ESRD
(p< 0.001) and coronary artery disease (pZ 0.017) all sig-
nificantly increased the risk of major amputation. Multivar-
iate analysis had similar results, gangrene (HR 5.0, 95% CI
1.6e15), ESRD (HR 12, 95% CI 4.3e35) and coronary heart
disease (HR 7.9, 95% CI 2.2e28).
Figure 2 Tissue healing time (including healing of ischemic
tissue lesions and surgical wounds) in 150 legs of patients
with and without diabetes treated with an infrainguinal bypass
operation due to CLI Fontaine IV.(Kaplan-Meier plots). Diabetes
was a risk factor for prolonged tissue healing time (log rank
test, pZ 0.001).
Table 4 Number and types of interventions in addition to
the infrainguinal bypass performed to treat 150 legs due to
CLI Fontaine IV
Leg reintervention Number (%)
of legs
Number of
interventions
Vascular interventions
Infrainguinal PTA prior to
infrainguinal bypass
22 (15%) 23
Inflow procedures prior to
infrainguinal bypass
15 (10%) 15
PTA 13
Reconstruction 2
Interventions to maintain,
restore graft patency
30 (20%) 38
Ulcer Healing and CLI 93During the first post-operative year 27 legs (18%) had
major amputation, 8 of which were performed despite
a patent graft.
Survival
The cumulative survival rate at 12 months was 73% (Fig. 3).
On univariate analysis age over 80 years (pZ 0.004), ESRD
(pZ 0.002) and gangrene (pZ 0.020) were associated
with increased risk of death. On multivariate analysis fac-
tors associated with an increased risk of death were ageFigure 3 Survival of 148 patients after an infrainguinal by-
pass operation due to CLI Fontaine IV. (Kaplan-Meier survival
curve).over 80 years (HR 2.6, 95% CI 1.3e5.3) and ESRD (HR 3.7,
95% CI 1.6e9.2).
The amputation-free survival rate at 12 months was 64%.
The amputation-free survival with completely healed
wounds was 50% at 12 months.
Limb re-intervention rates
In order to maintain graft patency or to treat recurrent
critical leg ischaemia during the first post-operative year
after the infrainguinal bypass 39 surgical and endovascular
secondary procedures were performed on 31 legs (20%)
(Table 4). A total number of 119 local procedures were per-
formed to treat the ischaemic tissue lesions on 73 legs
(49%). Most interventions were ulcer revisions or minor am-
putations. 14 legs (9%) required redo surgery because of
surgical wound infection. Haematoma evacuation from
the operative wound was performed once in 12 legs (8%)
and twice in one leg.Operative revisions of the
graft a
12
Inflow vessel PTA 5
Outflow vessel PTA 5
PTA of the graft 14
Trombolysis of the graft 1
Embolization of AV-fistula
of the graft
1
New infrainguinal
reconstruction
1 (1%) 1
Local interventions
Ulcer operations 73 (49%) 119
Minor amputation, revison 89
Skin grafting 25
Plastic surgery b 5
Surgery on operative wound 23 (15%) 29
Haematoma evacuation 14
Revision 14
Skin grafting 1
Major amputation 27 (18%) 27
a includes trombectomies, interpositiongrafts, patchangio-
plasties, distal extensiongrafts.
b includes local flaps, free flap transfers, calcaneal
resections.
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Patient loss to follow up is common (13e41%) in retrospec-
tive data and registry.8e11 This problem also is seen in pro-
spective series.12 In this prospective series we aimed to
record complete data.
Complete tissue healing is seldom an outcome which is
reported in studies of critical limb ischaemia.13 Hoffmann
et al. did a computerized literature research (1985e2005)
and identified 1915 papers on revascularization in CLI, com-
plete tissue healing for surgical procedures was reported in
only 6 studies. According to several studies, complete
tissue healing time is measured in months rather than
weeks.8e10,14e16
This study shows that tissue healing is a significant post-
operative problem, less than half of the patients achieved
complete tissue healing within a period of 6 months post-
operatively and at 12 months the overall healing rate was
not more than 75%. Chung et al. reported very similar tissue
healing rates.10 Other publications have reported higher
healing rates,9,14e16 but the studies differ from our study
either in terms of indication, intervention or definition of
tissue healing.
The diversity of wound care after infra-inguinal bypass
surgerymayhave increased theoverall tissuehealing times in
our study. Somewound care took place in other hospitals and
health centres.Wedid not assess the influence of the extent,
location and duration of the lesions on tissue healing time.
We identified diabetes as the dominant risk factor for
delayed tissue healing. Goshima et al. also reported pro-
longed healing times for patients with diabetes.8 Wo¨lfle
et al. recorded similar ulcer healing times of pedal lesions
in patients with and without diabetes who were available
for follow-up with patent grafts 1 year postoperatively.14
Greenhalgh et al. have studied the pathophysiology of
wound healing and concluded that vascular, neuropathic,
immunogenic and biochemical abnormalities contribute to
the complex diminished capacity for tissue repair in those
with diabetes.17
Several publications have suggested that the presence of
renal failure interferes with tissue healing and that patients
with renal failure may ultimately require major amputa-
tion.15,18,19 In this report, as in the studies published by
Chung et al.10 and Goshima et al.8 renal failure was not
a major risk for prolonged tissue healing although ESRD
was associated with major amputation and death. How-
ever, the small number of patients with ESRD in our study
prevents firm conclusions. In this study gangrene was not
associated with poor tissue healing. The presence of infec-
tion in an ischemic tissue lesion was not analysed sepa-
rately in our study. Infection may be an important factor
predicting tissue healing. In the study by Biancari et al.
increased CRP predicted worse graft patency as well as
diminished limb salvage and survival.18
Although in our study infection of the surgical wound
was encountered in about 10% of wounds, higher percent-
ages have been published.20,21 In the study by Virkkunen et
al., diabetes was reported to be a risk factor for superficial
wound infection.21 Diabetes was not a risk factor for surgi-
cal wound infection in our study. The different results may
be due to the fact that we included only postoperativecomplications that required surgical management in the
operating theatre, minor wound management in the outpa-
tient clinic or on the ward were not considered.
Our study shows acceptable separate results for healing
of tissue lesions, limb salvage and survival at 1 year after
the infrainguinal bypass. But when these endpoints were
combined, the success rate measured by amputation-free
survival with wounds fell to 50%. The low amputation-free
survival rate with completely healed tissue lesions reflects
the high morbidity of the patients treated and the slow
healing process of the ischemic tissue lesions. In our
hospital we have a very active policy to attempt revascu-
larization for all potentially mobile patients with CLI,
presuming that the leg is salvagable and the patient’s
condition allows surgery. Patient selection may be a tool to
improve amputation-free survival with healed lesions.
However, over the last decades a more active reconstruc-
tion policy has yielded regional decrease in major amputa-
tion rates in patients with CLI.22,23 An active
revascularization policy may affect short-term results neg-
atively as even very large ischaemic tissue defects are con-
sidered worth a salvage attempt.24
Conclusion
Amputation-free survival with healed wounds was attained
only in 50% of patients at 1 year due to the fact that
complete healing of ischaemic tissue lesions is slow and
a relatively large proportion of the patients die during the
first post-operative year.
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